The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's EV-to-FCF or its related term are showing as below:
SZSE:300267'
s EV-to-FCF Range Over the Past 10 Years
Min: -375.39 Med: -41.61 Max: 417.6
Current: 217.49
During the past 13 years, the highest EV-to-FCF of Hunan Er-Kang Pharmaceutical Co was 417.60. The lowest was -375.39. And the median was -41.61.
SZSE:300267's EV-to-FCF is ranked worse than 91.97% of 548
companies
in the Drug Manufacturers industry
Industry Median: 23.77
vs SZSE:300267: 217.49
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Er-Kang Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's EV-to-FCF falls into.
Hunan Er-Kang Pharmaceutical Co EV-to-FCF Calculation
Hunan Er-Kang Pharmaceutical Co's current Enterprise Value is ¥5,056 Mil.
Hunan Er-Kang Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Er-Kang Pharmaceutical Co (SZSE:300267) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hunan Er-Kang Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:
Hunan Er-Kang Pharmaceutical Co's share price for today is ¥2.64.
Hunan Er-Kang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.126.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hunan Er-Kang Pharmaceutical Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Hunan Er-Kang Pharmaceutical Co Business Description
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300267 has been successfully added to your 